These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 7998130)
1. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat. MacDonald AS; Sabr K; MacAuley MA; McAlister VC; Bitter-Suermann H; Lee T Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130 [No Abstract] [Full Text] [Related]
2. Effect of immunosuppression on chronic rejection in the rat aortic allograft model. Belitsky P; Gulanikar A; He G; Gupta R Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272 [No Abstract] [Full Text] [Related]
3. Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats. Lemström K; Bruning J; Koskinen P; Bruggeman C; Lautenschlager I; Häyry P Transplant Proc; 1994 Jun; 26(3):1727-8. PubMed ID: 8030105 [No Abstract] [Full Text] [Related]
4. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model. Little DM; Stoltenberg RL; Hullett DA; Sollinger HW Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445 [No Abstract] [Full Text] [Related]
5. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model. Lácha J; Lehmann M; Chadimová M; Brock J; Havlícková J Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129 [No Abstract] [Full Text] [Related]
6. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348 [No Abstract] [Full Text] [Related]
7. Oral leflunomide prevents small bowel allograft rejection in the rat. He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057 [No Abstract] [Full Text] [Related]
8. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression. Rintala JM; Savikko J; Rintala SE; von Willebrand E Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234 [TBL] [Abstract][Full Text] [Related]
11. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine. Chong AS; Shen J; Xiao F; Blinder L; Foster P; Sankary H; Williams JW Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344 [No Abstract] [Full Text] [Related]
12. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
13. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350 [TBL] [Abstract][Full Text] [Related]
14. Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model. Lirtzman RA; Gregory CR; Levitski RE; Griffey SM; Yeh LS; Patz JD; Morris RE Transplant Proc; 1996 Apr; 28(2):945-7. PubMed ID: 8623474 [No Abstract] [Full Text] [Related]
15. Promotion of corneal allograft survival with leflunomide. Niederkorn JY; Lang LS; Ross J; Mellon J; Robertson SM Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3783-5. PubMed ID: 8088966 [TBL] [Abstract][Full Text] [Related]
16. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide. Lin Y; Waer M Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224 [No Abstract] [Full Text] [Related]
17. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. Morris RE; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse R; Berry GJ Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888 [No Abstract] [Full Text] [Related]